SCHEMBL532188

SCHEMBL532188

CCC(CC)CC#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10416450 0.93
Boric Acid SCHEMBL27935964 0.89 ALDH1A1 (0.33)
SCHEMBL31742249 0.88 ALDH1A1 (0.37)
SCHEMBL8017928 0.83
SCHEMBL7922644 0.83
SCHEMBL7922642 0.83
SCHEMBL7983058 0.83
SCHEMBL8763250 0.79 ALDH1A1 (0.50)
SCHEMBL12299444 0.78 ALDH1A1 (0.36)
SCHEMBL28520747 0.78 TSHR (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895478-B2 Degradable polymer compositions and uses thereof ISP INVESTMENTS INC. (US) 2014-11-25 US claimed
US-20120157352-A1 DEGRADABLE POLYMER COMPOSITIONS AND USES THEREOF ISP INVESTMENTS INC. (US) 2012-06-21 US claimed
EP-2414456-A1 DEGRADABLE POLYMER COMPOSITIONS AND USES THEREOF Isp Investments Inc. (US) 2012-02-08 EP claimed
WO-2010114761-A1 DEGRADABLE POLYMER COMPOSITIONS AND USES THEREOF ISP INVESTMENT INC. (US) 2010-10-07 WO claimed
WO-2008032060-A1 4-BENZIMIDAZ0LYL-6-M0RPH0LIN0-2-PIPERAZINYLPYRIMIDINE DERIVATIVES AS P13K AND MTOR INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS ASTRAZENECA AB (SE) 2008-03-20 WO claimed
US-20240423937-A1 METHODS OF TREATING PAIN AND USES THEREOF UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2024-12-26 US disclosed
US-20240156765-A1 METHODS OF NEUROPROTECTION AND USES THEREOF UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2024-05-16 US disclosed
US-20240041808-A1 METHODS OF NEUROPROTECTION AND USES THEREOF UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2024-02-08 US disclosed
EP-4199905-A1 METHODS OF NEUROPROTECTION AND USES THEREOF Oculotherapy, LLC (US) 2023-06-28 EP disclosed
CN-116322664-A Method of neuroprotection and uses thereof 欧库罗治疗有限责任公司 2023-06-23 CN disclosed
WO-2023028490-A1 METHODS OF TREATING PAIN AND USES THEREOF OCULOTHERAPY, LLC (US) 2023-03-02 WO disclosed
WO-2022040622-A1 METHODS OF NEUROPROTECTION AND USES THEREOF OCULOTHERAPY, LLC (US) 2022-02-24 WO disclosed
US-5523400-A 3-(PYRROLIDIN-3-YLIDENE=CH-),7-((2-AMINOTHIAZOL-4-YL)HYDROX -IMINOACETYLAMINO-)-3-CEPHEM DERIVATIVES; BROAD SPECTRUM ANTIBIOTICS HOFFMANN-LA ROCHE INC. (US) 1996-06-04 US disclosed
US-5494666-A BETA-LACTAMASE INHIBITORS, ANTIBACTERIALS HOFFMANN-LA ROCHE INC. (US) 1996-02-27 US disclosed
US-5464617-A 1H-2,6a-diazacyclobut(cd)indene-6-carboxylic acid derivatives, antibiotics HOFFMANN-LA ROCHE INC. (US) 1995-11-07 US disclosed
EP-0620225-A1 Cephalosporin derivatives F. HOFFMANN-LA ROCHE AG (CH) 1994-10-19 EP disclosed
EP-0229944-A2 Novel tetrahydroisoquinoline derivatives SYNTEX (U.S.A.) INC. (US) 1987-07-29 EP disclosed
EP-0208921-A2 Hydroformylation of olefinic compounds in the presence of soluble cobalt salt catalysts and an organic nitrile promoter HENKEL CORPORATION (a Delaware corp.) (US) 1987-01-21 EP disclosed
US-4612403-A Hydroformylation of olefinic compounds in the presence of a cobalt catalyst and an organic nitrile promoter HENKEL CORPORATION (US) 1986-09-16 US disclosed
US-4219684-A REACTION OF AN OLEFIN WITH CARBON MONOXIDE AND HYDROGEN UOP INC. (US) 1980-08-26 US disclosed